- Home
- TELO vs ADAG Comparison
TELO vs ADAG Comparison
Compare TELO & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TELO
- ADAG
- Stock Information
- Founded
- TELO 2021
- ADAG 2011
- Country
- TELO United States
- ADAG China
- Employees
- TELO N/A
- ADAG N/A
- Industry
- TELO
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- TELO
- ADAG Health Care
- Exchange
- TELO NYSE
- ADAG Nasdaq
- Market Cap
- TELO 79.2M
- ADAG 76.3M
- IPO Year
- TELO 2024
- ADAG 2021
- Fundamental
- Price
- TELO $2.01
- ADAG $1.76
- Analyst Decision
- TELO
- ADAG Strong Buy
- Analyst Count
- TELO 0
- ADAG 1
- Target Price
- TELO N/A
- ADAG $8.00
- AVG Volume (30 Days)
- TELO 217.3K
- ADAG 36.9K
- Earning Date
- TELO 05-14-2025
- ADAG 07-24-2025
- Dividend Yield
- TELO N/A
- ADAG N/A
- EPS Growth
- TELO N/A
- ADAG N/A
- EPS
- TELO N/A
- ADAG N/A
- Revenue
- TELO N/A
- ADAG $103,204.00
- Revenue This Year
- TELO N/A
- ADAG $6,488.89
- Revenue Next Year
- TELO N/A
- ADAG $57.50
- P/E Ratio
- TELO N/A
- ADAG N/A
- Revenue Growth
- TELO N/A
- ADAG N/A
- 52 Week Low
- TELO $1.87
- ADAG $1.33
- 52 Week High
- TELO $8.40
- ADAG $3.58
- Technical
- Relative Strength Index (RSI)
- TELO 37.33
- ADAG 49.36
- Support Level
- TELO $1.88
- ADAG $1.85
- Resistance Level
- TELO $2.19
- ADAG $2.13
- Average True Range (ATR)
- TELO 0.19
- ADAG 0.17
- MACD
- TELO 0.01
- ADAG 0.01
- Stochastic Oscillator
- TELO 19.18
- ADAG 41.27
About TELO TELOMIR PHARMACEUTICALS INC
Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.